°æºÏ´ëÇб³ Ư¼ºÈ »ç¾÷´Ü (ÀÇ»ý¸í°úÇÐ) ÃÊû ÇØ¿Ü ¼®ÇРƯ° °øÁö
ÆäÀÌÁö Á¤º¸
ÀÛ¼ºÀÚ °ü¸®ÀÚ ÀÛ¼ºÀÏ12-09-19 12:11 Á¶È¸4,733ȸ ´ñ±Û0°Ç÷ºÎÆÄÀÏ
- 2010¾È¾ç»ùº´¿ø ÇÏ°è ¼ºêÀÎÅÏ.pdf (0byte) 80ȸ ´Ù¿î·Îµå DATE : 2015-02-27 13:59:02
º»¹®
°æºÏ´ëÇб³ Ư¼ºÈ »ç¾÷´Ü (ÀÇ»ý¸í°úÇÐ) ÃÊû ÇØ¿Ü ¼®ÇРƯ° °øÁö
ÀϽÃ: 2012³â 9¿ù 24ÀÏ (¿ù) ¿ÀÈÄ 5½Ã – 7½Ã
Àå¼Ò: °æºÏ´ëÇб³ ÀÇÇÐÀü¹®´ëÇпø º»°ü 1Ãþ Á¦ 1 ±³¼öȸÀǽÇ
¿¬ÀÚ ¹× ¿¬Á¦
1) Professor Soren Nielsen (Director, Water and Salt Research Center, University of Aarhus, Denmark)
¡°From aquaporin water channels in kidney to development of a new drug to prevent kidney injury associated with cardiac Surgery¡±
2) Professor Jorgen Frokiaer (Co- Director, Water and Salt Research Center, University of Aarhus, Denmark)
¡°Urinary tract obstruction induces early downregulation of AQP2: Redistribution and regulation by COX2 and Ang II¡±
¿¬ÀÚµéÀº ¼öºÐÅë·Î´Ü¹éÁú (aquaporin) ¿¬±¸ÀÇ ¼¼°èÀûÀÎ ¼®Çеé·Î¼ µ§¸¶Å© ¿ÀÈĽº ´ëÇб³ (University of Aarhus) ÀÇ°ú´ëÇÐ ³» ¡°Water and Salt Research Center¡±¸¦ À¯Ä¡ÇÏ¿© Áö³ 10³â °£ 450ÆíÀÇ °ü·Ã ³í¹®À» ¹ßÇ¥ÇÏ¿´°í, ¡°Action Pharma¡±¶ó´Â ½Å¾à°³¹ß ȸ»ç¸¦ â¾÷ÇÏ¿© °·ÂÇÑ Ç׿°ÁõÈ¿°ú°¡ ÀÖ´Â AP214 (alpha-melanocyte stimulating hormone analogue)¸¦ °³¹ßÇÏ¿´À¸¸ç, ÃÖ±Ù ¹Ì±¹ Abbott ȸ»ç¿¡¼ AP214¸¦ ÀμöÇÔ. À̹ø ÃÊû°¿¬¿¡¼´Â ¼öºÐÅë·Î´Ü¹éÁú »Ó¸¸ ¾Æ´Ï¶ó ½Å¾à°³¹ßÀÇ °æÇè¿¡ °üÇÑ °ÀǸ¦ ÇÒ ¿¹Á¤À¸·Î, ±³¼ö´Ô°ú ¿¬±¸¿ø, Çлý ¿©·¯ºÐÀÇ ¸¹Àº Âü¿©¸¦ ºÎŹµå¸³´Ï´Ù.
¹®ÀÇ: »ýÈÇм¼Æ÷»ý¹°Çб³½Ç ±ÇÅÂȯ ±³¼ö (420-4825, thkwon@knu.ac.kr)